The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 95 results:
Author Title Type [ Year(Desc)]
Filters: Author is Douma, Stella  [Clear All Filters]
2006
Vyzantiadis, T., Karagiannis A., Douma S., Harsoulis P., Vyzantiadis A., & Zamboulis C. (2006).  Vascular endothelial growth factor and nitric oxide serum levels in arterial hypertension.. Clin Exp Hypertens. 28(7), 603-9.
2008
Douma, S., Petidis K., Doumas M., Papaefthimiou P., Triantafyllou A., Kartali N., et al. (2008).  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.. Lancet. 371(9628), 1921-6.
Aslanidis, S., Pyrpasopoulou A., Douma S., & Triantafyllou A. (2008).  Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine.. Clin Rheumatol. 27(3), 377-80.
2009
Aslanidis, S., Pyrpasopoulou A., Soufleris K., Kazantzidou E., & Douma S. (2009).  Eosinophilic enteritis with ascites in a patient with overlap syndrome.. Case Rep Med. 2009, 734206.
Doumas, M., & Douma S. (2009).  Interventional management of resistant hypertension.. Lancet. 373(9671), 1228-30.
Gkaliagkousi, E., Douma S., Zamboulis C., & Ferro A. (2009).  Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension.. J Hypertens. 27(12), 2310-20.
2010
Doumas, M., Papademetriou V., Douma S., Faselis C., Tsioufis K., Gkaliagkousi E., et al. (2010).  Benefits from treatment and control of patients with resistant hypertension.. Int J Hypertens. 2011, 318549.
Gkaliagkousi, E., Passacquale G., Douma S., Zamboulis C., & Ferro A. (2010).  Platelet activation in essential hypertension: implications for antiplatelet treatment.. Am J Hypertens. 23(3), 229-36.
Triantafyllou, A., Douma S., Petidis K., Doumas M., Panagopoulou E., Pyrpasopoulou A., et al. (2010).  Prevalence, awareness, treatment and control of hypertension in an elderly population in Greece.. Rural Remote Health. 10(2), 1225.
Doumas, M., & Douma S. (2010).  Renal sympathetic denervation: the jury is still out.. Lancet. 376(9756), 1878-80.
Pyrpasopoulou, A., Douma S., Triantafyllou A., Simoulidou E., Samara M., Parapanisiou E., et al. (2010).  Response to rituximab and timeframe to relapse in rheumatoid arthritis patients: association with B-cell markers.. Mol Diagn Ther. 14(1), 43-8.
Aslanidis, S., Pyrpasopoulou A., Triantafyllou A., Anyfanti P., Zamboulis C., & Douma S. (2010).  Tumor necrosis factor antagonist-associated neutropenia: comment on the article by Hastings et al.. Arthritis Care Res (Hoboken). 62(12), 1813-5; author reply 1815.
2011
Pyrpasopoulou, A., Triantafyllou A., Anyfanti P., Douma S., & Aslanidis S. (2011).  Capillaroscopy as a screening test for clinical antiphospholipid syndrome.. Eur J Intern Med. 22(6), e158-9.
Papademetriou, V., Doumas M., Faselis C., Tsioufis C., Douma S., Gkaliagkousi E., et al. (2011).  Carotid baroreceptor stimulation for the treatment of resistant hypertension.. Int J Hypertens. 2011, 964394.
Anyfanti, P., Gavriilaki E., & Douma S. (2011).  Evaluating the true prevalence of resistant hypertension.. Hypertension. 58(4), e23; author reply e24-5.
Anyfanti, P., Gkaliagkousi E., & Douma S. (2011).  Letter by Anyfanti et al regarding article, "Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study".. Circulation. 124(20), e536; author reply e537.
Pyrpasopoulou, A., Douma S., Vassiliadis T., Chatzimichailidou S., Triantafyllou A., & Aslanidis S. (2011).  Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis.. Rheumatol Int. 31(3), 403-4.
2012
Pyrpasopoulou, A., Balaska E., Triantafyllou A., Anyfanti P., Aslanidis S., & Douma S. (2012).  B-cell activating factor levels in rheumatoid arthritis patients in response to treatment with biologics.. J Interferon Cytokine Res. 32(7), 338-40.
Gkaliagkousi, E., Doumas M., Gavriilaki E., Triantafyllou A., Vogiatzis K., Anyfanti P., et al. (2012).  Elevated levels of MMP-9 in untreated patients with stage I essential hypertension.. Clin Exp Hypertens. 34(8), 561-6.
Douma, S., Kamparoudis A., Petidis K., Anyfanti P., Doumas M., Gkaliagkousi E., et al. (2012).  Leiomyosarcoma of renal vein, initially resembling pheochromocytoma.. Clin Exp Hypertens. 34(6), 429-31.
Triantafyllou, A., Gavriilaki E., & Douma S. (2012).  Retinopathy assessment in hypertension is still puzzling.. Am J Hypertens. 25(7), 726.
Douma, S., Petidis K., Kamparoudis A., Gkaliagkousi E., Anyfanti P., Doumas M., et al. (2012).  Surgical management of primary aldosteronism. not everything that shines is gold.. Clin Exp Hypertens. 34(1), 53-6.
2013
Triantafyllou, A., Doumas M., Anyfanti P., Gkaliagkousi E., Zabulis X., Petidis K., et al. (2013).  Divergent retinal vascular abnormalities in normotensive persons and patients with never-treated, masked, white coat hypertension.. Am J Hypertens. 26(3), 318-25.
Gavriilaki, E., Gkaliagkousi E., Nikolaidou B., & Douma S. (2013).  Does vitamin D really contribute to excess cardiovascular risk in rheumatoid arthritis? Comment on the article by Haque et al.. Arthritis Care Res (Hoboken). 65(7), 1203.
Triantafyllou, A., Pyrpasopoulou A., Anyfanti P., Balaska E., Aslanidis S., & Douma S. (2013).  eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese.. Ann Rheum Dis. 72(5), e7.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.